Morgan Stanley has made several stock price adjustments, reflecting a blend of optimism and caution in the financial markets. Analyst Joe Laetsch raised the price target for CrowdStrike to $537 while affirming Overweight ratings for both Meta and Gilead, which saw price target increases. Conversely, the firm downgraded Atmos Energy to Equal Weight and reduced its price target to $172. These strategic moves are seen in light of anticipated S&P growth to around 7,800, paired with expected market volatility.
“Joe Laetsch from Morgan Stanley · initiated a · Hold rating on the stock”
“Joe Laetsch from Morgan Stanley · raised the · price target from $4 to $4.5”
“Analysts at Morgan Stanley · noted that · the energy services stocks have rallied out of the lows”
“Morgan Stanley analyst Keith Weiss · raised · CrowdStrike stock price target · from $515 to $537”
“Morgan Stanley · restated rating for Meta · Overweight · true”
“Morgan Stanley · raised the firm’s price target on Robinhood to · $147 · from $146”
“Morgan Stanley · has a rating on Robinhood · Equal Weight”
“Morgan Stanley · raised · the firm’s price target on AbbVie · $269 from $261”
“Morgan Stanley · downgraded · Atmos Energy Corporation (NYSE:ATO) · to Equal Weight from Overweight”
“Morgan Stanley · cut · price target on Atmos Energy Corporation (NYSE:ATO) · to $172 from $182”
“Morgan Stanley · is projecting · the S&P · around 7,800”
“Morgan Stanley · expects · volatility · along the way”
